Guardant Health Inc (NASDAQ: GH) is 53.78% higher on its value in year-to-date trading and has touched a low of $15.81 and a high of $49.86 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The GH stock was last observed hovering at around $47.21 in the last trading session, with the day’s loss setting it -0.23%.
Currently trading at $46.98, the stock is 24.30% and 33.48% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.78 million and changing -0.49% at the moment leaves the stock 68.59% off its SMA200. GH registered 104.88% gain for a year compared to 6-month loss of 47.13%. The firm has a 50-day simple moving average (SMA 50) of $34.8452 and a 200-day simple moving average (SMA200) of $27.74455.
The stock witnessed a 51.35% gain in the last 1 month and extending the period to 3 months gives it a 130.07%, and is 28.15% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 9.51% over the week and 6.29% over the month.
Guardant Health Inc (GH) has around 1779 employees, a market worth around $5.80B and $692.26M in sales. Profit margin for the company is -74.02%. Distance from 52-week low is 197.15% and -5.78% from its 52-week high. The company has generated returns on investments over the last 12 months (-40.93%).
with sales reaching $191.46M over the same period.The EPS is expected to grow by 22.15% this year, but quarterly earnings will post 29.10% year-over-year. Quarterly sales are estimated to grow 23.48% in year-over-year returns.
Guardant Health Inc (GH) Top Institutional Holders
384.0 institutions hold shares in Guardant Health Inc (GH), with institutional investors hold 110.33% of the company’s shares. The shares outstanding are 123.16M, and float is at 117.73M with Short Float at 6.62%. Institutions hold 105.18% of the Float.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 11.64 million shares valued at $336.07 million. The investor’s holdings represent 9.5609% of the GH Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 11.24 million shares valued at $324.55 million to account for 9.2332 of the shares outstanding. The other top investors are BAILLIE GIFFORD & CO which holds 6.09 million shares representing 5.0063% and valued at over $175.97 million, while DEEP TRACK CAPITAL, LP holds 3.6973 of the shares totaling 4.5 million with a market value of $129.96 million.
Guardant Health Inc (GH) Insider Activity
The most recent transaction is an insider sale by Tariq Musa, the company’s Director. SEC filings show that Tariq Musa sold 116 shares of the company’s common stock on Jan 17 ’25 at a price of $37.58 per share for a total of $4359.0. Following the sale, the insider now owns 2944.0 shares.
Still, SEC filings show that on Dec 18 ’24, Tariq Musa (Director) disposed off 116 shares at an average price of $34.85 for $4043.0. The insider now directly holds 2,810 shares of Guardant Health Inc (GH).
